| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.48e-09 | 188 | 56 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | neurohypophyseal hormone activity | 7.73e-06 | 2 | 56 | 2 | GO:0005185 | |
| GeneOntologyMolecularFunction | V1A vasopressin receptor binding | 2.31e-05 | 3 | 56 | 2 | GO:0031894 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A6 SLIT2 CRELD1 KRT34 LAMA1 LAMA4 CRELD2 LAMC2 LTBP4 SSPOP OTOG | 3.10e-05 | 891 | 56 | 11 | GO:0005198 |
| GeneOntologyMolecularFunction | vasopressin receptor binding | 4.62e-05 | 4 | 56 | 2 | GO:0031893 | |
| GeneOntologyMolecularFunction | growth factor binding | 7.56e-05 | 156 | 56 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 9.49e-05 | 85 | 56 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | neuregulin binding | 1.15e-04 | 6 | 56 | 2 | GO:0038132 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 3.95e-04 | 51 | 56 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | Roundabout binding | 5.01e-04 | 12 | 56 | 2 | GO:0048495 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 8.07e-04 | 65 | 56 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.09e-03 | 749 | 56 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | integrin binding | 1.47e-03 | 175 | 56 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 1.72e-03 | 22 | 56 | 2 | GO:0016864 | |
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 1.72e-03 | 22 | 56 | 2 | GO:0003756 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 2.99e-03 | 29 | 56 | 2 | GO:0043395 | |
| GeneOntologyMolecularFunction | neuropeptide hormone activity | 4.09e-03 | 34 | 56 | 2 | GO:0005184 | |
| GeneOntologyMolecularFunction | neuropeptide activity | 4.09e-03 | 34 | 56 | 2 | GO:0160041 | |
| GeneOntologyMolecularFunction | protein kinase activity | 6.52e-03 | 600 | 56 | 6 | GO:0004672 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 6.75e-03 | 268 | 56 | 4 | GO:0005539 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 7.85e-03 | 145 | 56 | 3 | GO:0004713 | |
| GeneOntologyBiologicalProcess | keratinization | 4.66e-11 | 87 | 52 | 8 | GO:0031424 | |
| GeneOntologyBiologicalProcess | epidermis development | KRTAP5-9 LCE4A KRT34 TMEM79 LAMC2 LCE1D LCE1A LCE2C LCE3B LCE2A LCE2B | 1.63e-08 | 461 | 52 | 11 | GO:0008544 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 2.28e-08 | 189 | 52 | 8 | GO:0030216 | |
| GeneOntologyBiologicalProcess | skin development | LCE4A TMEM79 ITGB4 LCE1D LCE1A ITGB6 LCE2C LCE3B LCE2A LCE2B | 2.67e-08 | 373 | 52 | 10 | GO:0043588 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 5.21e-07 | 284 | 52 | 8 | GO:0009913 | |
| GeneOntologyBiologicalProcess | axon guidance | 5.35e-07 | 285 | 52 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 5.50e-07 | 286 | 52 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | ASXL1 LCE4A KRT34 TMEM79 LAMA1 XDH LCE1D LCE1A LCE2C LCE3B LCE2A LCE2B | 1.28e-06 | 870 | 52 | 12 | GO:0030855 |
| GeneOntologyBiologicalProcess | motor neuron axon guidance | 1.77e-06 | 35 | 52 | 4 | GO:0008045 | |
| GeneOntologyBiologicalProcess | epithelium development | SLIT2 ASXL1 LCE4A KRT34 TMEM79 LAMA1 PLXNA4 XDH LCE1D LCE1A LCE2C LCE3B LCE2A LCE2B | 1.10e-05 | 1469 | 52 | 14 | GO:0060429 |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 1.87e-05 | 3 | 52 | 2 | GO:0021834 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 2.25e-05 | 22 | 52 | 3 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 2.25e-05 | 22 | 52 | 3 | GO:1902284 | |
| GeneOntologyBiologicalProcess | dorsal/ventral axon guidance | 3.73e-05 | 4 | 52 | 2 | GO:0033563 | |
| GeneOntologyBiologicalProcess | regulation of negative chemotaxis | 3.73e-05 | 4 | 52 | 2 | GO:0050923 | |
| GeneOntologyBiologicalProcess | maternal aggressive behavior | 3.73e-05 | 4 | 52 | 2 | GO:0002125 | |
| GeneOntologyBiologicalProcess | embryonic olfactory bulb interneuron precursor migration | 6.20e-05 | 5 | 52 | 2 | GO:0021831 | |
| GeneOntologyBiologicalProcess | central nervous system projection neuron axonogenesis | 7.12e-05 | 32 | 52 | 3 | GO:0021952 | |
| GeneOntologyBiologicalProcess | axonogenesis | 7.95e-05 | 566 | 52 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | branchiomotor neuron axon guidance | 1.30e-04 | 7 | 52 | 2 | GO:0021785 | |
| GeneOntologyBiologicalProcess | central nervous system neuron axonogenesis | 1.74e-04 | 43 | 52 | 3 | GO:0021955 | |
| GeneOntologyBiologicalProcess | axon development | 1.89e-04 | 642 | 52 | 8 | GO:0061564 | |
| GeneOntologyBiologicalProcess | regulation of female receptivity | 2.22e-04 | 9 | 52 | 2 | GO:0045924 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 2.70e-04 | 124 | 52 | 4 | GO:0007229 | |
| GeneOntologyBiologicalProcess | tangential migration from the subventricular zone to the olfactory bulb | 2.77e-04 | 10 | 52 | 2 | GO:0022028 | |
| GeneOntologyBiologicalProcess | negative chemotaxis | 2.89e-04 | 51 | 52 | 3 | GO:0050919 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron development | 3.38e-04 | 11 | 52 | 2 | GO:0021891 | |
| GeneOntologyBiologicalProcess | female mating behavior | 4.05e-04 | 12 | 52 | 2 | GO:0060180 | |
| GeneOntologyBiologicalProcess | regulation of axon guidance | 4.05e-04 | 12 | 52 | 2 | GO:1902667 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential migration | 4.78e-04 | 13 | 52 | 2 | GO:0021826 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential interneuron migration | 4.78e-04 | 13 | 52 | 2 | GO:0021843 | |
| GeneOntologyBiologicalProcess | aggressive behavior | 4.78e-04 | 13 | 52 | 2 | GO:0002118 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 5.28e-04 | 748 | 52 | 8 | GO:0048667 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SLIT2 ASXL1 MYCBP2 SLIT1 LAMA1 PLXNA4 LAMC2 ITGB6 NOTCH3 EPHA5 | 6.94e-04 | 1194 | 52 | 10 | GO:0000902 |
| GeneOntologyBiologicalProcess | circulatory system development | SLIT2 CRELD1 ASXL1 ERBB3 OXT LAMA1 PLXNA4 LAMA4 XDH NOTCH3 EPHA5 | 7.89e-04 | 1442 | 52 | 11 | GO:0072359 |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in axon guidance | 8.28e-04 | 17 | 52 | 2 | GO:0048841 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 8.33e-04 | 802 | 52 | 8 | GO:0048812 | |
| GeneOntologyBiologicalProcess | symbiont entry into host cell | 8.67e-04 | 169 | 52 | 4 | GO:0046718 | |
| GeneOntologyBiologicalProcess | neuron development | SLIT2 MYCBP2 SLIT1 LAMA1 PLXNA4 LAMC2 CAMK1 MFRP NOTCH3 OTOG EPHA5 | 8.89e-04 | 1463 | 52 | 11 | GO:0048666 |
| GeneOntologyBiologicalProcess | maternal behavior | 9.29e-04 | 18 | 52 | 2 | GO:0042711 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 9.55e-04 | 819 | 52 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | symbiont entry into host | 1.01e-03 | 176 | 52 | 4 | GO:0044409 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.01e-03 | 826 | 52 | 8 | GO:0048858 | |
| GeneOntologyBiologicalProcess | neuron projection development | SLIT2 MYCBP2 SLIT1 LAMA1 PLXNA4 LAMC2 CAMK1 NOTCH3 OTOG EPHA5 | 1.22e-03 | 1285 | 52 | 10 | GO:0031175 |
| GeneOntologyBiologicalProcess | parental behavior | 1.27e-03 | 21 | 52 | 2 | GO:0060746 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 1.57e-03 | 91 | 52 | 3 | GO:0033627 | |
| GeneOntologyBiologicalProcess | synapse organization | 1.58e-03 | 685 | 52 | 7 | GO:0050808 | |
| GeneOntologyBiologicalProcess | grooming behavior | 1.66e-03 | 24 | 52 | 2 | GO:0007625 | |
| GeneOntologyBiologicalProcess | retinal ganglion cell axon guidance | 1.66e-03 | 24 | 52 | 2 | GO:0031290 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 1.67e-03 | 202 | 52 | 4 | GO:0051963 | |
| GeneOntologyCellularComponent | intermediate filament | KRTAP5-9 KRT34 KRTAP1-4 KRTAP5-1 KRTAP5-3 KRTAP5-10 SCYGR6 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 6.19e-10 | 227 | 58 | 10 | GO:0005882 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A6 SLIT2 CRELD1 HTRA1 FCGBP MEGF6 LAMA1 LAMA4 LAMC2 CTSB LTBP4 SSPOP ITGB4 OTOG | 2.22e-09 | 656 | 58 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A6 SLIT2 CRELD1 HTRA1 FCGBP MEGF6 LAMA1 LAMA4 LAMC2 CTSB LTBP4 SSPOP ITGB4 OTOG | 2.31e-09 | 658 | 58 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRTAP5-9 KRT34 KRTAP1-4 KRTAP5-1 KRTAP5-3 KRTAP5-10 SCYGR6 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 2.57e-09 | 263 | 58 | 10 | GO:0045111 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A6 SLIT2 CRELD1 HTRA1 MEGF6 LAMA1 LAMA4 LAMC2 CTSB LTBP4 SSPOP ITGB4 | 1.92e-08 | 530 | 58 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 2.17e-05 | 59 | 58 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | basement membrane | 2.23e-05 | 122 | 58 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | supramolecular polymer | KRTAP5-9 COL4A6 KRT34 KRTAP1-4 KRTAP5-1 KRTAP5-3 KRTAP5-10 SCYGR6 LTBP4 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 8.33e-05 | 1187 | 58 | 12 | GO:0099081 |
| GeneOntologyCellularComponent | integrin complex | 9.50e-05 | 32 | 58 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRTAP5-9 KRT34 KRTAP1-4 KRTAP5-1 KRTAP5-3 KRTAP5-10 SCYGR6 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 1.64e-04 | 899 | 58 | 10 | GO:0099513 |
| GeneOntologyCellularComponent | receptor complex | 1.91e-04 | 581 | 58 | 8 | GO:0043235 | |
| GeneOntologyCellularComponent | laminin complex | 3.36e-04 | 10 | 58 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRTAP5-9 KRT34 KRTAP1-4 KRTAP5-1 KRTAP5-3 KRTAP5-10 SCYGR6 LTBP4 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 3.45e-04 | 1179 | 58 | 11 | GO:0099512 |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 2.83e-03 | 350 | 58 | 5 | GO:0098802 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 5.83e-03 | 785 | 58 | 7 | GO:0098797 | |
| Domain | EGF_1 | SLIT2 CRELD1 MEGF6 SLIT1 LAMA1 LAMA4 CRELD2 LAMC2 LTBP4 SSPOP ITGB4 ITGB6 ITGB7 NOTCH3 | 2.50e-14 | 255 | 57 | 14 | PS00022 |
| Domain | LCE | 3.20e-14 | 17 | 57 | 7 | PF14672 | |
| Domain | LCE | 3.20e-14 | 17 | 57 | 7 | IPR028205 | |
| Domain | EGF-like_CS | SLIT2 CRELD1 MEGF6 SLIT1 LAMA1 LAMA4 CRELD2 LAMC2 LTBP4 ITGB4 ITGB6 ITGB7 NOTCH3 EPHA5 | 3.44e-14 | 261 | 57 | 14 | IPR013032 |
| Domain | Growth_fac_rcpt_ | CRELD1 ERBB3 HTRA1 MEGF6 SLIT1 LAMA1 INSRR CRELD2 LAMC2 LTBP4 NOTCH3 EPHA5 | 3.84e-14 | 156 | 57 | 12 | IPR009030 |
| Domain | EGF_2 | SLIT2 CRELD1 MEGF6 SLIT1 LAMA1 CRELD2 LAMC2 LTBP4 SSPOP ITGB4 ITGB6 ITGB7 NOTCH3 EPHA5 | 4.24e-14 | 265 | 57 | 14 | PS01186 |
| Domain | SPRR/LCE | 1.90e-12 | 28 | 57 | 7 | IPR026075 | |
| Domain | KAP | KRTAP5-9 KRTAP1-4 KRTAP5-1 KRTAP5-3 KRTAP5-10 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 7.69e-12 | 58 | 57 | 8 | IPR002494 |
| Domain | EGF-like_dom | SLIT2 CRELD1 FCGBP MEGF6 SLIT1 LAMA1 LAMA4 CRELD2 LAMC2 LTBP4 NOTCH3 OTOG | 1.01e-11 | 249 | 57 | 12 | IPR000742 |
| Domain | EGF | SLIT2 CRELD1 FCGBP MEGF6 SLIT1 LAMA1 LAMA4 CRELD2 LAMC2 LTBP4 NOTCH3 | 1.10e-10 | 235 | 57 | 11 | SM00181 |
| Domain | Laminin_EGF | 1.58e-09 | 38 | 57 | 6 | IPR002049 | |
| Domain | EGF_Ca-bd_CS | 1.75e-08 | 97 | 57 | 7 | IPR018097 | |
| Domain | EGF_CA | 2.02e-08 | 99 | 57 | 7 | PS01187 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.25e-08 | 106 | 57 | 7 | IPR000152 | |
| Domain | EGF_3 | 3.61e-08 | 235 | 57 | 9 | PS50026 | |
| Domain | Unchr_dom_Cys-rich | 5.46e-08 | 13 | 57 | 4 | IPR014853 | |
| Domain | C8 | 5.46e-08 | 13 | 57 | 4 | SM00832 | |
| Domain | Laminin_EGF | 6.70e-08 | 35 | 57 | 5 | PF00053 | |
| Domain | TIL_dom | 7.63e-08 | 14 | 57 | 4 | IPR002919 | |
| Domain | EGF_CA | 8.60e-08 | 122 | 57 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 9.62e-08 | 124 | 57 | 7 | IPR001881 | |
| Domain | VWD | 1.38e-07 | 16 | 57 | 4 | SM00216 | |
| Domain | VWF_type-D | 1.38e-07 | 16 | 57 | 4 | IPR001846 | |
| Domain | VWFD | 1.38e-07 | 16 | 57 | 4 | PS51233 | |
| Domain | VWD | 1.38e-07 | 16 | 57 | 4 | PF00094 | |
| Domain | Furin_repeat | 2.31e-07 | 18 | 57 | 4 | IPR006212 | |
| Domain | FU | 2.31e-07 | 18 | 57 | 4 | SM00261 | |
| Domain | VWC_out | 2.92e-07 | 19 | 57 | 4 | SM00215 | |
| Domain | ASX_HYDROXYL | 5.89e-07 | 100 | 57 | 6 | PS00010 | |
| Domain | Integrin_bsu_tail | 9.35e-07 | 7 | 57 | 3 | IPR012896 | |
| Domain | Integrin_B_tail | 9.35e-07 | 7 | 57 | 3 | SM01242 | |
| Domain | Integrin_B_tail | 9.35e-07 | 7 | 57 | 3 | PF07965 | |
| Domain | Cys_knot_C | 9.40e-07 | 25 | 57 | 4 | IPR006207 | |
| Domain | CTCK_2 | 9.40e-07 | 25 | 57 | 4 | PS01225 | |
| Domain | EGF_extracell | 1.06e-06 | 60 | 57 | 5 | IPR013111 | |
| Domain | EGF_2 | 1.06e-06 | 60 | 57 | 5 | PF07974 | |
| Domain | Integrin_beta | 1.49e-06 | 8 | 57 | 3 | PF00362 | |
| Domain | INB | 1.49e-06 | 8 | 57 | 3 | SM00187 | |
| Domain | Integrin_bsu_VWA | 1.49e-06 | 8 | 57 | 3 | IPR002369 | |
| Domain | hEGF | 1.51e-06 | 28 | 57 | 4 | PF12661 | |
| Domain | Integrin_bsu | 2.23e-06 | 9 | 57 | 3 | IPR015812 | |
| Domain | Integin_beta_N | 2.23e-06 | 9 | 57 | 3 | IPR033760 | |
| Domain | INTEGRIN_BETA | 2.23e-06 | 9 | 57 | 3 | PS00243 | |
| Domain | PSI_integrin | 2.23e-06 | 9 | 57 | 3 | PF17205 | |
| Domain | EGF_Lam | 3.80e-06 | 35 | 57 | 4 | SM00180 | |
| Domain | Fol_N | 4.37e-06 | 11 | 57 | 3 | IPR003645 | |
| Domain | FOLN | 4.37e-06 | 11 | 57 | 3 | SM00274 | |
| Domain | LAM_G_DOMAIN | 5.33e-06 | 38 | 57 | 4 | PS50025 | |
| Domain | TIL | 5.81e-06 | 12 | 57 | 3 | PF01826 | |
| Domain | C8 | 5.81e-06 | 12 | 57 | 3 | PF08742 | |
| Domain | EGF_CA | 6.38e-06 | 86 | 57 | 5 | PF07645 | |
| Domain | Keratin_B2 | 6.56e-06 | 40 | 57 | 4 | PF01500 | |
| Domain | Laminin_G_2 | 6.56e-06 | 40 | 57 | 4 | PF02210 | |
| Domain | VWF_dom | 8.00e-06 | 42 | 57 | 4 | IPR001007 | |
| Domain | Neurhyp_horm | 9.15e-06 | 2 | 57 | 2 | PD001676 | |
| Domain | Neurohypophysial_hormone_CS | 9.15e-06 | 2 | 57 | 2 | IPR022423 | |
| Domain | Hormone_4 | 9.15e-06 | 2 | 57 | 2 | PF00220 | |
| Domain | Hormone_5 | 9.15e-06 | 2 | 57 | 2 | PF00184 | |
| Domain | - | 9.15e-06 | 2 | 57 | 2 | 2.60.9.10 | |
| Domain | NEUROHYPOPHYS_HORM | 9.15e-06 | 2 | 57 | 2 | PS00264 | |
| Domain | NH | 9.15e-06 | 2 | 57 | 2 | SM00003 | |
| Domain | PSI | 9.66e-06 | 44 | 57 | 4 | IPR016201 | |
| Domain | LamG | 9.66e-06 | 44 | 57 | 4 | SM00282 | |
| Domain | Galactose-bd-like | 9.88e-06 | 94 | 57 | 5 | IPR008979 | |
| Domain | PSI | 1.16e-05 | 46 | 57 | 4 | SM00423 | |
| Domain | CTCK_1 | 2.13e-05 | 18 | 57 | 3 | PS01185 | |
| Domain | Laminin_G | 2.93e-05 | 58 | 57 | 4 | IPR001791 | |
| Domain | CT | 3.98e-05 | 22 | 57 | 3 | SM00041 | |
| Domain | Neurhyp_horm | 5.47e-05 | 4 | 57 | 2 | IPR000981 | |
| Domain | - | 7.25e-05 | 73 | 57 | 4 | 2.60.120.260 | |
| Domain | Laminin_aI | 9.10e-05 | 5 | 57 | 2 | IPR009254 | |
| Domain | Laminin_I | 9.10e-05 | 5 | 57 | 2 | PF06008 | |
| Domain | Laminin_II | 9.10e-05 | 5 | 57 | 2 | PF06009 | |
| Domain | Laminin_domII | 9.10e-05 | 5 | 57 | 2 | IPR010307 | |
| Domain | EGF_LAM_2 | 1.03e-04 | 30 | 57 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.03e-04 | 30 | 57 | 3 | PS01248 | |
| Domain | Integrin_bsu_cyt_dom | 1.36e-04 | 6 | 57 | 2 | IPR014836 | |
| Domain | Integrin_b_cyt | 1.36e-04 | 6 | 57 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 1.36e-04 | 6 | 57 | 2 | PF08725 | |
| Domain | Furin-like | 1.90e-04 | 7 | 57 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 1.90e-04 | 7 | 57 | 2 | IPR000494 | |
| Domain | APC_su10/DOC_dom | 1.90e-04 | 7 | 57 | 2 | IPR004939 | |
| Domain | DUF3456 | 1.90e-04 | 7 | 57 | 2 | PF11938 | |
| Domain | DOC | 1.90e-04 | 7 | 57 | 2 | PS51284 | |
| Domain | DUF3456 | 1.90e-04 | 7 | 57 | 2 | IPR021852 | |
| Domain | Furin-like_Cys-rich_dom | 1.90e-04 | 7 | 57 | 2 | IPR006211 | |
| Domain | Recep_L_domain | 1.90e-04 | 7 | 57 | 2 | PF01030 | |
| Domain | - | 1.90e-04 | 7 | 57 | 2 | 3.80.20.20 | |
| Domain | APC10 | 1.90e-04 | 7 | 57 | 2 | SM01337 | |
| Domain | ANAPC10 | 1.90e-04 | 7 | 57 | 2 | PF03256 | |
| Domain | - | 2.02e-04 | 95 | 57 | 4 | 2.60.120.200 | |
| Domain | VWC | 2.11e-04 | 38 | 57 | 3 | SM00214 | |
| Domain | Keratin_B2_2 | 2.28e-04 | 39 | 57 | 3 | PF13885 | |
| Domain | LAMININ_IVA | 2.53e-04 | 8 | 57 | 2 | PS51115 | |
| Domain | Laminin_B | 2.53e-04 | 8 | 57 | 2 | PF00052 | |
| Domain | LamB | 2.53e-04 | 8 | 57 | 2 | SM00281 | |
| Domain | Laminin_IV | 2.53e-04 | 8 | 57 | 2 | IPR000034 | |
| Domain | Laminin_G_1 | 4.94e-04 | 11 | 57 | 2 | PF00054 | |
| Domain | ConA-like_dom | 5.40e-04 | 219 | 57 | 5 | IPR013320 | |
| Domain | EGF | 5.92e-04 | 126 | 57 | 4 | PF00008 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP5-9 LCE4A KRT34 KRTAP1-4 KRTAP5-1 KRTAP5-3 KRTAP5-10 LCE1D KRTAP5-5 LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 2.48e-18 | 217 | 45 | 16 | M27640 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP5-9 SLIT2 LCE4A KRT34 KRTAP1-4 SLIT1 LAMA1 PLXNA4 KRTAP5-1 KRTAP5-3 KRTAP5-10 ITGB4 LCE1D KRTAP5-5 LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A EPHA5 LCE2B | 4.97e-11 | 1432 | 45 | 22 | M509 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 6.41e-09 | 129 | 45 | 8 | M27649 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 7.82e-09 | 84 | 45 | 7 | M7098 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.71e-08 | 300 | 45 | 10 | M610 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.54e-08 | 30 | 45 | 5 | M27216 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 9.99e-08 | 258 | 45 | 9 | MM14572 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.21e-07 | 15 | 45 | 4 | MM14922 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 3.28e-07 | 46 | 45 | 5 | M239 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.16e-06 | 59 | 45 | 5 | M27218 | |
| Pathway | WP_FOCAL_ADHESION | 1.91e-06 | 187 | 45 | 7 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION | 2.90e-06 | 199 | 45 | 7 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.90e-06 | 199 | 45 | 7 | M7253 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 4.93e-06 | 11 | 45 | 3 | M158 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.14e-05 | 61 | 45 | 4 | M27103 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 4.36e-05 | 302 | 45 | 7 | M39719 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 5.15e-05 | 23 | 45 | 3 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 5.15e-05 | 23 | 45 | 3 | M47720 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.65e-05 | 66 | 45 | 4 | M18 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 7.07e-05 | 326 | 45 | 7 | MM15917 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 7.51e-05 | 26 | 45 | 3 | M47 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 7.51e-05 | 26 | 45 | 3 | M47719 | |
| Pathway | WP_PI3KAKT_SIGNALING | 9.04e-05 | 339 | 45 | 7 | M39736 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 9.42e-05 | 28 | 45 | 3 | M47655 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 9.83e-05 | 76 | 45 | 4 | M27219 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.16e-04 | 30 | 45 | 3 | M27772 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 1.16e-04 | 30 | 45 | 3 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 1.16e-04 | 30 | 45 | 3 | M47718 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 1.45e-04 | 84 | 45 | 4 | M3228 | |
| Pathway | REACTOME_VASOPRESSIN_LIKE_RECEPTORS | 1.48e-04 | 6 | 45 | 2 | M27289 | |
| Pathway | REACTOME_VASOPRESSIN_LIKE_RECEPTORS | 1.48e-04 | 6 | 45 | 2 | MM14989 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.55e-04 | 33 | 45 | 3 | M39503 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.89e-04 | 90 | 45 | 4 | M631 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 2.43e-04 | 96 | 45 | 4 | M39834 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.98e-04 | 41 | 45 | 3 | M27778 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 3.54e-04 | 9 | 45 | 2 | MM15117 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 4.41e-04 | 10 | 45 | 2 | M27348 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 4.47e-04 | 47 | 45 | 3 | M39829 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 5.38e-04 | 11 | 45 | 2 | M27372 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.01e-03 | 140 | 45 | 4 | M587 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.02e-03 | 15 | 45 | 2 | M27161 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 1.21e-03 | 66 | 45 | 3 | MM15925 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 1.31e-03 | 17 | 45 | 2 | M212 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.65e-03 | 19 | 45 | 2 | MM15512 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 1.68e-03 | 74 | 45 | 3 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 1.68e-03 | 74 | 45 | 3 | M16376 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.82e-03 | 76 | 45 | 3 | MM14867 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.03e-03 | 79 | 45 | 3 | M27643 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 2.34e-03 | 83 | 45 | 3 | M8728 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.50e-03 | 85 | 45 | 3 | M16441 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 2.57e-03 | 439 | 45 | 6 | M42563 | |
| Pathway | WP_VITAMIN_D_RECEPTOR_PATHWAY | 2.81e-03 | 185 | 45 | 4 | M39718 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 2.85e-03 | 25 | 45 | 2 | M1547 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 2.94e-03 | 90 | 45 | 3 | M835 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 3.32e-03 | 27 | 45 | 2 | M33 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.09e-03 | 30 | 45 | 2 | MM15517 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 4.19e-03 | 102 | 45 | 3 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 4.19e-03 | 102 | 45 | 3 | MM15830 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 4.37e-03 | 31 | 45 | 2 | MM1343 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.65e-03 | 32 | 45 | 2 | MM14924 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.65e-03 | 32 | 45 | 2 | MM14854 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 4.65e-03 | 213 | 45 | 4 | M18306 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.71e-03 | 114 | 45 | 3 | MM14571 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.18e-03 | 37 | 45 | 2 | M27134 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 6.51e-03 | 38 | 45 | 2 | MM14874 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 6.73e-03 | 121 | 45 | 3 | M39823 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 6.85e-03 | 39 | 45 | 2 | MM14601 | |
| Pubmed | KRTAP5-9 KRTAP5-1 KRTAP5-3 KRTAP5-10 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 4.76e-17 | 13 | 59 | 7 | 15144888 | |
| Pubmed | 4.67e-15 | 22 | 59 | 7 | 15854049 | ||
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | 6.71e-15 | 23 | 59 | 7 | 11698679 | |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | KRTAP5-9 INTS5 LCE4A KRT34 KRTAP5-1 KRTAP5-3 ITGB4 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 1.20e-13 | 630 | 59 | 15 | 36949045 |
| Pubmed | 1.45e-13 | 16 | 59 | 6 | 17410201 | ||
| Pubmed | COL4A6 SLIT2 CRELD1 MEGF6 LAMA1 LAMA4 CRELD2 CTSB LTBP4 SSPOP | 4.08e-13 | 175 | 59 | 10 | 28071719 | |
| Pubmed | 1.43e-08 | 167 | 59 | 7 | 22159717 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 2.05e-08 | 101 | 59 | 6 | 23382219 | |
| Pubmed | 1.09e-07 | 26 | 59 | 4 | 24742657 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.16e-07 | 135 | 59 | 6 | 28675934 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 2.14e-07 | 248 | 59 | 7 | 24006456 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 4.19e-07 | 560 | 59 | 9 | 21653829 | |
| Pubmed | 5.52e-07 | 10 | 59 | 3 | 9034910 | ||
| Pubmed | 5.52e-07 | 10 | 59 | 3 | 11784026 | ||
| Pubmed | 6.52e-07 | 40 | 59 | 4 | 27068110 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 7.58e-07 | 11 | 59 | 3 | 21524702 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 7.58e-07 | 11 | 59 | 3 | 23472759 | |
| Pubmed | 1.01e-06 | 12 | 59 | 3 | 11381080 | ||
| Pubmed | Expression of laminin receptors in schwann cell differentiation: evidence for distinct roles. | 1.01e-06 | 12 | 59 | 3 | 12843252 | |
| Pubmed | 1.01e-06 | 12 | 59 | 3 | 9396756 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 2.08e-06 | 15 | 59 | 3 | 15895400 | |
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 2.08e-06 | 15 | 59 | 3 | 12921739 | |
| Pubmed | 2.56e-06 | 16 | 59 | 3 | 17601529 | ||
| Pubmed | 2.56e-06 | 16 | 59 | 3 | 17356169 | ||
| Pubmed | Vasopressin and oxytocin excite MCH neurons, but not other lateral hypothalamic GABA neurons. | 2.83e-06 | 2 | 59 | 2 | 22262306 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 3768139 | ||
| Pubmed | Expression of the vasopressin and oxytocin genes in human hypothalami. | 2.83e-06 | 2 | 59 | 2 | 4065330 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 2991279 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12137942 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12515855 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 29609987 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 8863731 | ||
| Pubmed | Vasopressin and oxytocin in CSF and plasma of patients with aneurysmal subarachnoid haemorrhage. | 2.83e-06 | 2 | 59 | 2 | 24412107 | |
| Pubmed | Synthesis, transport, and release of posterior pituitary hormones. | 2.83e-06 | 2 | 59 | 2 | 6153132 | |
| Pubmed | Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes. | 2.83e-06 | 2 | 59 | 2 | 12200164 | |
| Pubmed | The contributions of oxytocin and vasopressin pathway genes to human behavior. | 2.83e-06 | 2 | 59 | 2 | 22245314 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 24086383 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 31538678 | ||
| Pubmed | Oxytocin and vasopressin: social neuropeptides with complex neuromodulatory functions. | 2.83e-06 | 2 | 59 | 2 | 23589638 | |
| Pubmed | [Oxytocin and vasopressin: sexual differences and clinical implications]. | 2.83e-06 | 2 | 59 | 2 | 37200960 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21899794 | ||
| Pubmed | Directional guidance of neuronal migration in the olfactory system by the protein Slit. | 2.83e-06 | 2 | 59 | 2 | 10432110 | |
| Pubmed | On the nature of oxytocin and vasopressin from human pituitary. | 2.83e-06 | 2 | 59 | 2 | 13591312 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 30859180 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 20144509 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23403283 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23320558 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 14962074 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12944509 | ||
| Pubmed | Slit1 and slit2 proteins control the development of the lateral olfactory tract. | 2.83e-06 | 2 | 59 | 2 | 12097499 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 19500216 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 36113782 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 19120108 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 36979340 | ||
| Pubmed | Identification of human neurophysins: complete amino acid sequences of MSEL- and VLDV-neurophysins. | 2.83e-06 | 2 | 59 | 2 | 6574452 | |
| Pubmed | Ontogeny of the vasopressin and oxytocin RNAs in the mouse hypothalamus. | 2.83e-06 | 2 | 59 | 2 | 9678638 | |
| Pubmed | Sociality, pathogen avoidance, and the neuropeptides oxytocin and arginine vasopressin. | 2.83e-06 | 2 | 59 | 2 | 21960250 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 19672816 | ||
| Pubmed | 3.72e-06 | 18 | 59 | 3 | 11311202 | ||
| Pubmed | 4.40e-06 | 64 | 59 | 4 | 22261194 | ||
| Pubmed | 5.18e-06 | 20 | 59 | 3 | 22911573 | ||
| Pubmed | The transcription factor neurogenin 2 restricts cell migration from the cortex to the striatum. | 5.18e-06 | 20 | 59 | 3 | 11748150 | |
| Pubmed | Canonical notch signaling functions as a commitment switch in the epidermal lineage. | 6.03e-06 | 21 | 59 | 3 | 17079689 | |
| Pubmed | 6.38e-06 | 153 | 59 | 5 | 25037231 | ||
| Pubmed | Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain. | 8.48e-06 | 3 | 59 | 2 | 16162649 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 39034759 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 28715127 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 20729552 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 9813312 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 23617461 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 17314405 | ||
| Pubmed | A molecular mechanism for the heparan sulfate dependence of slit-robo signaling. | 8.48e-06 | 3 | 59 | 2 | 17062560 | |
| Pubmed | Conserved modularity and potential for alternate splicing in mouse and human Slit genes. | 8.48e-06 | 3 | 59 | 2 | 12141424 | |
| Pubmed | Specification of oxytocinergic and vasopressinergic circuits in the developing mouse brain. | 8.48e-06 | 3 | 59 | 2 | 33990685 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 16840550 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 10934193 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 25863961 | ||
| Pubmed | Laminin isoform-specific promotion of adhesion and migration of human bone marrow progenitor cells. | 8.48e-06 | 3 | 59 | 2 | 12393739 | |
| Pubmed | Late-onset retinal degeneration pathology due to mutations in CTRP5 is mediated through HTRA1. | 8.48e-06 | 3 | 59 | 2 | 31385385 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 2176709 | ||
| Pubmed | New neurons follow the flow of cerebrospinal fluid in the adult brain. | 8.48e-06 | 3 | 59 | 2 | 16410488 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 20695903 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 10364234 | ||
| Pubmed | Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion. | 8.48e-06 | 3 | 59 | 2 | 24065825 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 12531518 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 1382574 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.02e-05 | 79 | 59 | 4 | 18757743 | |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 1.32e-05 | 27 | 59 | 3 | 31541017 | |
| Pubmed | 1.47e-05 | 28 | 59 | 3 | 18617019 | ||
| Pubmed | A distinct hypothalamus-to-β cell circuit modulates insulin secretion. | 1.69e-05 | 4 | 59 | 2 | 35108515 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 22917688 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 22673183 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 31371721 | ||
| Pubmed | Multiple roles for slits in the control of cell migration in the rostral migratory stream. | 1.69e-05 | 4 | 59 | 2 | 14960623 | |
| Pubmed | Contralateral migration of oculomotor neurons is regulated by Slit/Robo signaling. | 1.69e-05 | 4 | 59 | 2 | 27770832 | |
| Pubmed | Slits contribute to the guidance of retinal ganglion cell axons in the mammalian optic tract. | 1.69e-05 | 4 | 59 | 2 | 16828733 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 9201115 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 8573717 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 11089561 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 20092567 | ||
| Interaction | HOXA1 interactions | KRTAP5-9 SLIT2 CRELD1 LCE4A MEGF6 KRT34 SLIT1 CRELD2 KRTAP5-3 LTBP4 ITGB4 LCE1D LCE1A LCE2C KRTAP5-11 LCE2A NOTCH3 LCE2B | 2.11e-18 | 356 | 56 | 18 | int:HOXA1 |
| Interaction | KRTAP5-2 interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 1.23e-17 | 62 | 56 | 11 | int:KRTAP5-2 |
| Interaction | KRTAP5-4 interactions | KRTAP5-9 LCE4A KRTAP5-1 KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 LCE2A LCE2B | 1.48e-17 | 63 | 56 | 11 | int:KRTAP5-4 |
| Interaction | KRTAP5-6 interactions | KRTAP5-9 LCE4A KRTAP5-1 KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 2.42e-17 | 94 | 56 | 12 | int:KRTAP5-6 |
| Interaction | LCE3B interactions | KRTAP5-9 KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 4.43e-17 | 46 | 56 | 10 | int:LCE3B |
| Interaction | KRTAP4-4 interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 2.81e-16 | 81 | 56 | 11 | int:KRTAP4-4 |
| Interaction | LCE1B interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 4.91e-16 | 85 | 56 | 11 | int:LCE1B |
| Interaction | LCE2C interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 7.31e-16 | 88 | 56 | 11 | int:LCE2C |
| Interaction | LCE1F interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 1.22e-15 | 92 | 56 | 11 | int:LCE1F |
| Interaction | KRTAP4-2 interactions | KRTAP5-9 LCE4A KRTAP5-3 ITGB4 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 1.64e-15 | 132 | 56 | 12 | int:KRTAP4-2 |
| Interaction | CRCT1 interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 2.20e-15 | 66 | 56 | 10 | int:CRCT1 |
| Interaction | LCE1E interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2B | 3.02e-15 | 68 | 56 | 10 | int:LCE1E |
| Interaction | KRTAP9-8 interactions | KRTAP5-9 LCE4A KRTAP5-3 ITGB4 LCE1D LCE1A LCE2C LCE3B KRTAP5-11 LCE2A LCE2B | 3.16e-15 | 100 | 56 | 11 | int:KRTAP9-8 |
| Interaction | LCE2A interactions | KRTAP5-9 LCE4A LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 3.52e-15 | 69 | 56 | 10 | int:LCE2A |
| Interaction | KRTAP9-2 interactions | KRTAP5-9 LCE4A KRTAP5-3 ITGB4 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 7.19e-15 | 149 | 56 | 12 | int:KRTAP9-2 |
| Interaction | RGS17 interactions | LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-11 LCE2A LCE2B | 7.76e-15 | 48 | 56 | 9 | int:RGS17 |
| Interaction | KRTAP4-5 interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 LCE2A LCE2B | 9.75e-15 | 76 | 56 | 10 | int:KRTAP4-5 |
| Interaction | KRTAP10-1 interactions | KRTAP5-9 LCE4A KRTAP5-1 KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 9.92e-15 | 153 | 56 | 12 | int:KRTAP10-1 |
| Interaction | LCE1C interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-11 LCE2A LCE2B | 1.12e-14 | 77 | 56 | 10 | int:LCE1C |
| Interaction | SMCP interactions | KRTAP5-9 LCE4A KRT34 KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 | 1.46e-14 | 79 | 56 | 10 | int:SMCP |
| Interaction | LCE4A interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 1.67e-14 | 80 | 56 | 10 | int:LCE4A |
| Interaction | LCE2B interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 LCE2A LCE2B | 1.90e-14 | 81 | 56 | 10 | int:LCE2B |
| Interaction | LCE1A interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 2.77e-14 | 84 | 56 | 10 | int:LCE1A |
| Interaction | KRTAP10-6 interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-11 LCE2A LCE2B | 4.50e-14 | 88 | 56 | 10 | int:KRTAP10-6 |
| Interaction | LCE5A interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-11 LCE2A LCE2B | 5.68e-14 | 90 | 56 | 10 | int:LCE5A |
| Interaction | KRTAP4-11 interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 LCE2A LCE2B | 7.12e-14 | 92 | 56 | 10 | int:KRTAP4-11 |
| Interaction | KRTAP9-3 interactions | KRTAP5-9 LCE4A KRTAP5-3 ITGB4 LCE1D LCE1A LCE2C LCE3B KRTAP5-11 LCE2A LCE2B | 1.39e-13 | 140 | 56 | 11 | int:KRTAP9-3 |
| Interaction | KRTAP5-11 interactions | KRTAP5-9 LCE4A LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A | 1.65e-13 | 66 | 56 | 9 | int:KRTAP5-11 |
| Interaction | KRTAP5-3 interactions | KRTAP5-9 LCE4A KRTAP5-1 KRTAP5-3 LCE1D LCE1A LCE2C LCE3B LCE2B | 1.65e-13 | 66 | 56 | 9 | int:KRTAP5-3 |
| Interaction | LCE1D interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE2C LCE3B KRTAP5-11 LCE2A LCE2B | 2.87e-13 | 70 | 56 | 9 | int:LCE1D |
| Interaction | LCE2D interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C KRTAP5-7 LCE2A LCE2B | 4.84e-13 | 74 | 56 | 9 | int:LCE2D |
| Interaction | LCE3A interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 6.21e-13 | 76 | 56 | 9 | int:LCE3A |
| Interaction | KRTAP4-12 interactions | KRTAP5-9 LCE4A KRTAP5-1 KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 LCE2A LCE2B | 6.54e-13 | 161 | 56 | 11 | int:KRTAP4-12 |
| Interaction | ADAMTSL4 interactions | KRTAP5-9 LCE4A SLIT1 KRTAP5-3 CTSB ITGB4 LCE1D LCE1A LCE2C KRTAP5-7 LCE2A LCE2B | 6.59e-13 | 217 | 56 | 12 | int:ADAMTSL4 |
| Interaction | KRTAP1-5 interactions | 7.31e-13 | 48 | 56 | 8 | int:KRTAP1-5 | |
| Interaction | KRTAP1-1 interactions | KRTAP5-9 LCE4A SLIT1 KRTAP5-3 ITGB4 LCE1D LCE1A LCE2C LCE3B KRTAP5-11 LCE2A LCE2B | 7.35e-13 | 219 | 56 | 12 | int:KRTAP1-1 |
| Interaction | KRTAP10-9 interactions | KRTAP5-9 LCE4A KRTAP5-3 ITGB4 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 2.28e-12 | 241 | 56 | 12 | int:KRTAP10-9 |
| Interaction | KRTAP1-3 interactions | KRTAP5-9 LCE4A KRTAP5-3 ITGB4 LCE1D LCE1A LCE2C LCE3B KRTAP5-11 LCE2A LCE2B | 2.83e-12 | 184 | 56 | 11 | int:KRTAP1-3 |
| Interaction | CYSRT1 interactions | KRTAP5-9 INTS5 LCE4A KRT34 SLIT1 KRTAP5-3 ITGB4 LCE1D LCE1A LCE2C LCE3B KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 5.87e-12 | 511 | 56 | 15 | int:CYSRT1 |
| Interaction | KRTAP10-11 interactions | 8.28e-12 | 64 | 56 | 8 | int:KRTAP10-11 | |
| Interaction | TRIM42 interactions | LCE4A KRT34 SLIT1 LCE1D LCE1A LCE2C KRTAP5-7 KRTAP5-11 LCE2A LCE2B | 9.58e-12 | 149 | 56 | 10 | int:TRIM42 |
| Interaction | KRTAP10-5 interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-11 LCE2A LCE2B | 1.95e-11 | 160 | 56 | 10 | int:KRTAP10-5 |
| Interaction | KRTAP5-7 interactions | 1.96e-11 | 71 | 56 | 8 | int:KRTAP5-7 | |
| Interaction | RGS20 interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C KRTAP5-11 LCE2A LCE2B | 3.57e-11 | 118 | 56 | 9 | int:RGS20 |
| Interaction | KRTAP10-8 interactions | KRTAP5-9 INTS5 LCE4A SLIT1 KRTAP5-3 ITGB4 LCE1D LCE1A LCE2C LCE3B KRTAP5-11 LCE2A LCE2B | 5.50e-11 | 401 | 56 | 13 | int:KRTAP10-8 |
| Interaction | KRTAP5-9 interactions | KRTAP5-9 LCE4A KRTAP5-3 LCE1D LCE1A LCE2C LCE3B KRTAP5-11 LCE2A LCE2B | 2.05e-10 | 203 | 56 | 10 | int:KRTAP5-9 |
| Interaction | KRTAP2-3 interactions | 2.13e-10 | 95 | 56 | 8 | int:KRTAP2-3 | |
| Interaction | KRTAP2-4 interactions | 3.50e-10 | 101 | 56 | 8 | int:KRTAP2-4 | |
| Interaction | KRTAP10-7 interactions | KRTAP5-9 LCE4A KRTAP5-3 ITGB4 LCE1D LCE1A LCE2C LCE3B KRTAP5-11 LCE2A LCE2B | 4.24e-10 | 293 | 56 | 11 | int:KRTAP10-7 |
| Interaction | NBPF19 interactions | KRTAP5-9 LCE4A KRTAP5-3 ITGB4 LCE1D LCE1A LCE2C KRTAP5-11 LCE2A LCE2B | 7.87e-10 | 233 | 56 | 10 | int:NBPF19 |
| Interaction | LCE3D interactions | 1.23e-09 | 73 | 56 | 7 | int:LCE3D | |
| Interaction | KRTAP12-3 interactions | 6.62e-09 | 146 | 56 | 8 | int:KRTAP12-3 | |
| Interaction | NUFIP2 interactions | KRTAP5-9 CRELD1 LCE4A MEGF6 KRTAP5-3 LTBP4 LCE1D LCE2C KRTAP5-11 NOTCH3 LCE2B | 1.68e-08 | 417 | 56 | 11 | int:NUFIP2 |
| Interaction | LCE3C interactions | 3.06e-08 | 67 | 56 | 6 | int:LCE3C | |
| Interaction | NOTCH2NLA interactions | KRTAP5-9 LCE4A KRTAP5-3 ITGB4 LCE1D LCE1A LCE2C KRTAP5-11 LCE2A LCE2B | 8.51e-08 | 381 | 56 | 10 | int:NOTCH2NLA |
| Interaction | KRTAP17-1 interactions | 2.16e-07 | 48 | 56 | 5 | int:KRTAP17-1 | |
| Interaction | OTX1 interactions | 2.35e-07 | 155 | 56 | 7 | int:OTX1 | |
| Interaction | VASN interactions | 2.92e-07 | 160 | 56 | 7 | int:VASN | |
| Interaction | CREB5 interactions | 3.45e-07 | 164 | 56 | 7 | int:CREB5 | |
| Interaction | KRTAP11-1 interactions | 5.38e-07 | 108 | 56 | 6 | int:KRTAP11-1 | |
| Interaction | SPRY1 interactions | 6.32e-07 | 111 | 56 | 6 | int:SPRY1 | |
| Interaction | LCE3E interactions | 6.71e-07 | 60 | 56 | 5 | int:LCE3E | |
| Interaction | KRTAP12-1 interactions | 8.58e-07 | 63 | 56 | 5 | int:KRTAP12-1 | |
| Interaction | KRTAP10-10 interactions | 8.95e-07 | 27 | 56 | 4 | int:KRTAP10-10 | |
| Interaction | KRTAP12-2 interactions | 1.46e-06 | 128 | 56 | 6 | int:KRTAP12-2 | |
| Interaction | TGFB1 interactions | 2.53e-06 | 317 | 56 | 8 | int:TGFB1 | |
| Interaction | DHRS1 interactions | 1.21e-05 | 51 | 56 | 4 | int:DHRS1 | |
| Interaction | GRN interactions | 1.23e-05 | 281 | 56 | 7 | int:GRN | |
| Interaction | SLC39A7 interactions | 1.30e-05 | 187 | 56 | 6 | int:SLC39A7 | |
| Interaction | LELP1 interactions | 1.34e-05 | 17 | 56 | 3 | int:LELP1 | |
| Interaction | KRTAP12-4 interactions | 1.41e-05 | 53 | 56 | 4 | int:KRTAP12-4 | |
| Interaction | MANEA interactions | 2.32e-05 | 60 | 56 | 4 | int:MANEA | |
| Interaction | ALPP interactions | 2.32e-05 | 123 | 56 | 5 | int:ALPP | |
| Interaction | CATSPER1 interactions | 2.61e-05 | 126 | 56 | 5 | int:CATSPER1 | |
| Interaction | VWC2 interactions | 2.65e-05 | 62 | 56 | 4 | int:VWC2 | |
| Interaction | FBLN1 interactions | 2.92e-05 | 129 | 56 | 5 | int:FBLN1 | |
| Interaction | PHLDA1 interactions | 3.39e-05 | 66 | 56 | 4 | int:PHLDA1 | |
| Interaction | NR4A3 interactions | 4.04e-05 | 69 | 56 | 4 | int:NR4A3 | |
| Interaction | CHIC2 interactions | 5.05e-05 | 73 | 56 | 4 | int:CHIC2 | |
| Interaction | ZNF408 interactions | 5.12e-05 | 145 | 56 | 5 | int:ZNF408 | |
| Interaction | POU4F2 interactions | 8.35e-05 | 83 | 56 | 4 | int:POU4F2 | |
| Interaction | KRTAP6-3 interactions | 8.41e-05 | 161 | 56 | 5 | int:KRTAP6-3 | |
| Interaction | KRTAP4-1 interactions | 8.64e-05 | 31 | 56 | 3 | int:KRTAP4-1 | |
| Interaction | NID2 interactions | 9.58e-05 | 86 | 56 | 4 | int:NID2 | |
| Interaction | CYP21A2 interactions | 1.05e-04 | 33 | 56 | 3 | int:CYP21A2 | |
| Interaction | MACO1 interactions | 1.24e-04 | 175 | 56 | 5 | int:MACO1 | |
| Interaction | SPRY3 interactions | 1.25e-04 | 35 | 56 | 3 | int:SPRY3 | |
| Interaction | FBXO2 interactions | 1.37e-04 | 411 | 56 | 7 | int:FBXO2 | |
| Interaction | CRY2 interactions | 2.01e-04 | 194 | 56 | 5 | int:CRY2 | |
| Interaction | FUCA2 interactions | 2.32e-04 | 43 | 56 | 3 | int:FUCA2 | |
| Interaction | SDC3 interactions | 2.48e-04 | 44 | 56 | 3 | int:SDC3 | |
| Interaction | ICAM4 interactions | 2.83e-04 | 46 | 56 | 3 | int:ICAM4 | |
| Interaction | IGFBP6 interactions | 3.85e-04 | 51 | 56 | 3 | int:IGFBP6 | |
| Interaction | MFAP5 interactions | 4.08e-04 | 52 | 56 | 3 | int:MFAP5 | |
| Interaction | TSPAN4 interactions | 4.31e-04 | 53 | 56 | 3 | int:TSPAN4 | |
| Interaction | ZFP41 interactions | 5.35e-04 | 57 | 56 | 3 | int:ZFP41 | |
| Interaction | KRTAP5-1 interactions | 5.80e-04 | 13 | 56 | 2 | int:KRTAP5-1 | |
| Interaction | MEOX2 interactions | 6.44e-04 | 697 | 56 | 8 | int:MEOX2 | |
| Interaction | IGSF5 interactions | 6.75e-04 | 14 | 56 | 2 | int:IGSF5 | |
| Interaction | FBLN2 interactions | 8.21e-04 | 66 | 56 | 3 | int:FBLN2 | |
| Cytoband | 1q21.3 | 9.71e-09 | 117 | 59 | 6 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 8.93e-07 | 404 | 59 | 7 | chr1q21 | |
| Cytoband | 11q13.4 | 1.27e-04 | 75 | 59 | 3 | 11q13.4 | |
| Cytoband | 11p15.5 | 4.84e-04 | 118 | 59 | 3 | 11p15.5 | |
| Cytoband | 3p25.3 | 1.55e-03 | 45 | 59 | 2 | 3p25.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 2.80e-03 | 454 | 59 | 4 | chr11q13 | |
| Cytoband | 17q21.2 | 3.71e-03 | 70 | 59 | 2 | 17q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 6.02e-03 | 564 | 59 | 4 | chr11p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q32 | 6.99e-03 | 97 | 59 | 2 | chr7q32 | |
| Cytoband | 20p13 | 7.70e-03 | 102 | 59 | 2 | 20p13 | |
| GeneFamily | Late cornified envelope proteins | 5.61e-15 | 18 | 41 | 7 | 627 | |
| GeneFamily | Keratin associated proteins | KRTAP5-9 KRTAP1-4 KRTAP5-1 KRTAP5-3 KRTAP5-10 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 1.09e-10 | 109 | 41 | 8 | 619 |
| GeneFamily | CD molecules|Integrin beta subunits | 9.01e-07 | 9 | 41 | 3 | 1159 | |
| GeneFamily | Laminin subunits | 2.35e-06 | 12 | 41 | 3 | 626 | |
| GeneFamily | Fibronectin type III domain containing | 5.67e-03 | 160 | 41 | 3 | 555 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | SLIT2 CRELD1 SLIT1 LAMA1 KCP LAMA4 CRELD2 LAMC2 LTBP4 SSPOP OTOG | 3.17e-13 | 191 | 57 | 11 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | SLIT2 CRELD1 SLIT1 LAMA1 KCP LAMA4 CRELD2 LAMC2 LTBP4 SSPOP OTOG | 4.21e-13 | 196 | 57 | 11 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | COL4A6 SLIT2 CRELD1 SLIT1 LAMA1 KCP LAMA4 CRELD2 LAMC2 LTBP4 SSPOP OTOG | 5.24e-13 | 270 | 57 | 12 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL4A6 SLIT2 CRELD1 SLIT1 LAMA1 KCP LAMA4 CRELD2 LAMC2 LTBP4 SSPOP OTOG | 6.51e-13 | 275 | 57 | 12 | M5884 |
| Coexpression | NABA_MATRISOME | COL4A6 SLIT2 CRELD1 HTRA1 MEGF6 CST9 SLIT1 LAMA1 PLXNA4 KCP LAMA4 CRELD2 LAMC2 MFRP CTSB LTBP4 SSPOP OTOG | 2.19e-12 | 1008 | 57 | 18 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A6 SLIT2 CRELD1 HTRA1 MEGF6 CST9 SLIT1 LAMA1 PLXNA4 KCP LAMA4 CRELD2 LAMC2 CTSB LTBP4 SSPOP OTOG | 3.33e-11 | 1026 | 57 | 17 | M5889 |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_UP | 7.20e-08 | 49 | 57 | 5 | MM452 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.73e-06 | 40 | 57 | 4 | M5887 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | 3.24e-05 | 574 | 57 | 8 | MM820 | |
| Coexpression | BENPORATH_EED_TARGETS | COL4A6 SLIT2 ASXL1 CNNM2 HTRA1 SLIT1 INSRR ZCCHC2 PCDH10 EPHA5 | 8.52e-05 | 1059 | 57 | 10 | M7617 |
| Coexpression | GU_PDEF_TARGETS_DN | 9.10e-05 | 40 | 57 | 3 | M10480 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 9.80e-05 | 41 | 57 | 3 | M47988 | |
| Coexpression | CERVERA_SDHB_TARGETS_1_UP | 1.37e-04 | 120 | 57 | 4 | M15549 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | 1.72e-04 | 544 | 57 | 7 | M1936 | |
| Coexpression | WANG_BARRETTS_ESOPHAGUS_UP | 2.00e-04 | 52 | 57 | 3 | M6225 | |
| Coexpression | ZEILSTRA_CD44_TARGETS_UP | 2.07e-04 | 10 | 57 | 2 | MM603 | |
| Coexpression | WHITESIDE_CISPLATIN_RESISTANCE_UP | 2.52e-04 | 11 | 57 | 2 | M1499 | |
| Coexpression | GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP | 2.68e-04 | 143 | 57 | 4 | M8819 | |
| CoexpressionAtlas | skin | 2.38e-06 | 456 | 55 | 9 | skin | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | KRTAP5-9 KRTAP1-4 KRTAP5-1 KRTAP5-3 KRTAP5-10 VSIG8 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 3.40e-13 | 146 | 59 | 9 | 522c32103c24fc26836bb5b642083904682d9292 |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor-3|TCGA-Testes / Sample_Type by Project: Shred V9 | 3.26e-10 | 125 | 59 | 7 | 5f90de494b53ecce6455034f3ed5dccdbb2c29ca | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 4.68e-09 | 183 | 59 | 7 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.57e-07 | 199 | 59 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.65e-07 | 200 | 59 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | (01)_IL1RL1+|World / shred by cell type by condition | 2.65e-07 | 200 | 59 | 6 | 501420901bf3ec1b050e0d14596a9f9f3fdfc928 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-06 | 184 | 59 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-06 | 184 | 59 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-06 | 184 | 59 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-06 | 187 | 59 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.30e-06 | 190 | 59 | 5 | 3b9abc25b17e7295356ded57ff2ca519fa9f2686 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-06 | 190 | 59 | 5 | c1bfc1960a3df49c0f459454a7363804c32418ee | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.44e-06 | 191 | 59 | 5 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.58e-06 | 192 | 59 | 5 | 1990dc8a81594018a5bf596be99d0b5f0af0f58f | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.58e-06 | 192 | 59 | 5 | 845cc9c18b4436b07dd3ce7980052683937546d2 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.58e-06 | 192 | 59 | 5 | c72a082c93a8825adbfef37f889ba3a7052f201b | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.72e-06 | 193 | 59 | 5 | 5f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.80e-06 | 200 | 59 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.80e-06 | 200 | 59 | 5 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.68e-05 | 130 | 59 | 4 | eb16a8f8f62add5fdd29c78d4608b6d1a06767f1 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.93e-05 | 152 | 59 | 4 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 153 | 59 | 4 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | CV-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 5.19e-05 | 154 | 59 | 4 | 26bf81a86700db7e65c2384ffe94ed4253ea4047 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-SMG_basal_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.73e-05 | 158 | 59 | 4 | adad97e6cf479d42791c5ba9cbc5f15f469322bf | |
| ToppCell | CV-Healthy-3|CV / Virus stimulation, Condition and Cluster | 6.17e-05 | 161 | 59 | 4 | fd4a79385ea967b9900dc76a3add813b894a3a28 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-RGCs_early_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.78e-05 | 165 | 59 | 4 | e460e03992781073cd836a655f15dda3157cea55 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.11e-05 | 167 | 59 | 4 | f01b96173deda0239fa482989873cf308e49d48c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 167 | 59 | 4 | 3dfec2fcc36caa6e394efae5e540a6fa28759977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 167 | 59 | 4 | 95b3b5ba3414729f0460a26a0deca48de0cbe33e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 167 | 59 | 4 | 9480739587d51e67a281778b9bddd7b5ffc3ad92 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.11e-05 | 167 | 59 | 4 | 5fc85a05124cd2324e1b8ff940193880f83cd8af | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 170 | 59 | 4 | 03cb4e508356f85372a588c8d1c6babf2a012683 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 171 | 59 | 4 | 9498c35b2a2c3a339dc8c5d49c8ec20d8ad52753 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 171 | 59 | 4 | db544252f98e073e5bb4bec4a110cd58e6434435 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-05 | 172 | 59 | 4 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-05 | 172 | 59 | 4 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.15e-05 | 173 | 59 | 4 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.33e-05 | 174 | 59 | 4 | a0ccda8fd6f55251cdeff24cf66e72e4a31d2104 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Pde1a_(dSPN)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.43e-05 | 64 | 59 | 3 | def8cf047ec3ba3c40bb759d0910838df857f05b | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Pde1a_(dSPN)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.43e-05 | 64 | 59 | 3 | cec968dc404934fa9888d445d7c4cd2df7f3cc7a | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.90e-05 | 177 | 59 | 4 | 6f6cf93893daac6ae228df36219ee3acf8de8f97 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.29e-05 | 179 | 59 | 4 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.50e-05 | 180 | 59 | 4 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.50e-05 | 180 | 59 | 4 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.70e-05 | 181 | 59 | 4 | 6e8c5460021d3999daec58e3d6661a6fa998fd16 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.91e-05 | 182 | 59 | 4 | fa16e194f04250149c82e86551270b244cbc8af4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 183 | 59 | 4 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.01e-04 | 183 | 59 | 4 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 183 | 59 | 4 | c7e94fe3e7669db9304b249979fef7a69c30a143 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 183 | 59 | 4 | 274076a0978bce2bd53a1732045f18ef0f2d9985 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 184 | 59 | 4 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 184 | 59 | 4 | 61caaa31975e05c9a6512079c791fed5a9e2d39f | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 184 | 59 | 4 | 03da0f0f89f1ca5a3ccca1e22972f3129464e68e | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 184 | 59 | 4 | 9ed2a65a4ca0ebbbb89ace61027522f93369843d | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 184 | 59 | 4 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 184 | 59 | 4 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 184 | 59 | 4 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | Endothelial-E|World / shred on cell class and cell subclass (v4) | 1.03e-04 | 184 | 59 | 4 | b4c561924c508536fd2112e91e32176b95fdf63a | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.03e-04 | 184 | 59 | 4 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 184 | 59 | 4 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 69 | 59 | 3 | 3da27f504e82277fa4a8fb67d60fc26dee0a414f | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 186 | 59 | 4 | 29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 186 | 59 | 4 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 186 | 59 | 4 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 186 | 59 | 4 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 187 | 59 | 4 | ed69e7cbd6fb59363b0e26f24887fc49405397ce | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 187 | 59 | 4 | 13056622d9921ee0b03325701d94df82ffbaa5d4 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.12e-04 | 188 | 59 | 4 | 50b27fc12347ca16bd62333baf345c83cb422a8f | |
| ToppCell | Endothelial-Endothelial-E|Endothelial / shred on cell class and cell subclass (v4) | 1.12e-04 | 188 | 59 | 4 | 2777eb7689b271c199021fe7d9db88ccebff14de | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 188 | 59 | 4 | 61422c7919ca0ea02d6be4302f11b169a3ce35e5 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 188 | 59 | 4 | 18698f0b22ccbc2b93759acc1c8dbdb30a6b5a16 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 189 | 59 | 4 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 1.15e-04 | 189 | 59 | 4 | 8030a353473da34ae92429f2d822171a2e94248f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 189 | 59 | 4 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | 18-Airway-Epithelial-Submucosal_gland|Airway / Age, Tissue, Lineage and Cell class | 1.15e-04 | 189 | 59 | 4 | c1ea2dc44cf5340378e56e0ffc2e6f64e6c95a58 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 189 | 59 | 4 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | normal_Lung-Fibroblasts-Undetermined|normal_Lung / Location, Cell class and cell subclass | 1.17e-04 | 190 | 59 | 4 | 30d4658bcc6796f0cdf54cc029f4bb904b13ef66 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 1.17e-04 | 190 | 59 | 4 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 1.17e-04 | 190 | 59 | 4 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-04 | 190 | 59 | 4 | d87b9e9ca863270a9c7f61674271a6440c97d1f4 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-04 | 190 | 59 | 4 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-04 | 191 | 59 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 191 | 59 | 4 | 9fc674a58f20b47255e4457d5195c8cff17b0414 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.19e-04 | 191 | 59 | 4 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 191 | 59 | 4 | c379a499dabf3c9ed80f47adbb2d949821c5b053 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 192 | 59 | 4 | 285a9d332a1e07b94f222d4b518dd56928b9e075 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 192 | 59 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 192 | 59 | 4 | 1b228f0929b505de82a39bf64c837887b0e56701 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 192 | 59 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.22e-04 | 192 | 59 | 4 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.24e-04 | 193 | 59 | 4 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-04 | 193 | 59 | 4 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 193 | 59 | 4 | 80380358f44c2f4781676ec0f1fa94d4c69080d6 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell-SMG_serous_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-04 | 193 | 59 | 4 | 56145861ef5e7655db9ad0d11b82f72dcadf285d | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-04 | 193 | 59 | 4 | 3d1710a6060d3a70994a206334ccb16cd63e5f20 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-04 | 193 | 59 | 4 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | facs-Pancreas-Exocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 193 | 59 | 4 | c3161a14a40323a58aa202c8a1d6ea0e9c2b9814 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 193 | 59 | 4 | 22ebc3f586eb0aabc5785e468c88d7416c624ff4 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-04 | 193 | 59 | 4 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 194 | 59 | 4 | e2db75f4de114631b8bda4e188f84446545538b7 | |
| Drug | trypanothione disulfide | 1.51e-06 | 140 | 58 | 6 | CID000115098 | |
| Drug | AC1L1G72 | 2.55e-06 | 11 | 58 | 3 | CID000003553 | |
| Drug | colchine | 5.48e-06 | 383 | 58 | 8 | CID000002833 | |
| Drug | Demoxytocin | 6.38e-06 | 2 | 58 | 2 | CID000008229 | |
| Drug | AC1NURZQ | 6.38e-06 | 2 | 58 | 2 | CID005490952 | |
| Drug | P9-28 | 6.38e-06 | 2 | 58 | 2 | CID000139428 | |
| Drug | Pro-arg-gly-amide | 6.38e-06 | 2 | 58 | 2 | CID000170777 | |
| Drug | 2-phenylalanine | 6.38e-06 | 2 | 58 | 2 | CID000031722 | |
| Drug | Phasvatocin | 6.38e-06 | 2 | 58 | 2 | CID000192334 | |
| Drug | ethyl cyclohexylideneacetate | 6.38e-06 | 2 | 58 | 2 | CID000073776 | |
| Drug | Cgp 29325 | 6.38e-06 | 2 | 58 | 2 | CID000175772 | |
| Drug | Glumitocin | 6.38e-06 | 2 | 58 | 2 | CID003084054 | |
| Drug | AC1L1C2F | 8.98e-06 | 110 | 58 | 5 | CID000001711 | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 1.02e-05 | 195 | 58 | 6 | 5665_UP | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.15e-05 | 199 | 58 | 6 | 4115_UP | |
| Drug | kalinin | 1.17e-05 | 55 | 58 | 4 | CID000032518 | |
| Drug | LG 5 | 1.66e-05 | 60 | 58 | 4 | CID011840957 | |
| Drug | AC1O4Q3H | 1.91e-05 | 3 | 58 | 2 | CID006410744 | |
| Drug | ranatensin C | 1.91e-05 | 3 | 58 | 2 | CID005488559 | |
| Drug | Annetocin | 1.91e-05 | 3 | 58 | 2 | CID000197651 | |
| Drug | L 366811 | 1.91e-05 | 3 | 58 | 2 | CID003083084 | |
| Drug | dE-Vvt | 1.91e-05 | 3 | 58 | 2 | CID003083171 | |
| Drug | AC1L45X9 | 1.91e-05 | 3 | 58 | 2 | CID000151233 | |
| Drug | L 366682 | 1.91e-05 | 3 | 58 | 2 | CID000196819 | |
| Drug | Dglvp | 1.91e-05 | 3 | 58 | 2 | CID000169434 | |
| Drug | Asvatocin | 1.91e-05 | 3 | 58 | 2 | CID000192333 | |
| Drug | Sikvav | 3.06e-05 | 24 | 58 | 3 | CID005487517 | |
| Drug | 1-piperidinocyclohexanecarbonitrile | 3.47e-05 | 25 | 58 | 3 | CID000062529 | |
| Drug | Phenypressin | 3.81e-05 | 4 | 58 | 2 | CID003082314 | |
| Drug | Pressinamide | 3.81e-05 | 4 | 58 | 2 | CID003082272 | |
| Drug | Dpvdavp | 3.81e-05 | 4 | 58 | 2 | CID003081540 | |
| Drug | Vasotocin | 3.81e-05 | 4 | 58 | 2 | ctd:D014668 | |
| Drug | Z-PLG | 3.81e-05 | 4 | 58 | 2 | CID000151917 | |
| Drug | Conopressin G | 3.81e-05 | 4 | 58 | 2 | CID000163847 | |
| Drug | LMWH | 4.24e-05 | 663 | 58 | 9 | CID000000772 | |
| Drug | 2-amino-5-methylpyridine | 4.47e-05 | 77 | 58 | 4 | CID000015348 | |
| Drug | losartan | 4.77e-05 | 378 | 58 | 7 | CID000003961 | |
| Drug | YIGSR | 4.94e-05 | 79 | 58 | 4 | CID000123977 | |
| Drug | AC1L1B58 | 5.47e-05 | 29 | 58 | 3 | CID000001288 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 5.79e-05 | 162 | 58 | 5 | CID000072363 | |
| Drug | Mpomeovt | 6.35e-05 | 5 | 58 | 2 | CID000122244 | |
| Drug | Tgot | 6.35e-05 | 5 | 58 | 2 | CID003082106 | |
| Drug | AGN 190851 | 6.35e-05 | 5 | 58 | 2 | CID000131829 | |
| Drug | L 365209 | 6.35e-05 | 5 | 58 | 2 | CID000196774 | |
| Drug | Felypressin | 6.35e-05 | 5 | 58 | 2 | CID000005956 | |
| Drug | NSC 714187 | 6.58e-05 | 85 | 58 | 4 | CID005288693 | |
| Drug | L-366,509 | 9.50e-05 | 6 | 58 | 2 | CID003083288 | |
| Drug | 5-methoxy-N-isobutanoyltryptamine | 9.50e-05 | 6 | 58 | 2 | CID006455231 | |
| Drug | L-371,257 | 9.50e-05 | 6 | 58 | 2 | CID006918320 | |
| Drug | D3PVP | 9.50e-05 | 6 | 58 | 2 | CID000195824 | |
| Drug | oxypressin | 9.50e-05 | 6 | 58 | 2 | CID000164712 | |
| Drug | Azo-dye Rr6 Hapten | 9.50e-05 | 6 | 58 | 2 | CID006400893 | |
| Drug | Deavp | 9.50e-05 | 6 | 58 | 2 | CID000114715 | |
| Drug | imatinib | 1.07e-04 | 430 | 58 | 7 | CID000005291 | |
| Drug | pyrazolo(3,4-d)pyrimidine | 1.15e-04 | 98 | 58 | 4 | ctd:C014175 | |
| Drug | Pro-arg | 1.15e-04 | 37 | 58 | 3 | CID000151004 | |
| Drug | Calcort | 1.24e-04 | 38 | 58 | 3 | CID000026709 | |
| Drug | Ikvav | 1.24e-04 | 38 | 58 | 3 | CID000131343 | |
| Drug | IEM-611 | 1.33e-04 | 7 | 58 | 2 | CID000039794 | |
| Drug | B3852 | 1.33e-04 | 7 | 58 | 2 | CID000086074 | |
| Drug | Vdavp | 1.33e-04 | 7 | 58 | 2 | CID000171113 | |
| Drug | Tridihexethyl chloride; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.36e-04 | 194 | 58 | 5 | 3526_UP | |
| Drug | AC1Q6PMM | 1.45e-04 | 40 | 58 | 3 | CID000003211 | |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 7497_UP | |
| Drug | L 366948 | 1.77e-04 | 8 | 58 | 2 | CID000188397 | |
| Drug | 13beta-methyl 19-nor-steroid | 1.77e-04 | 8 | 58 | 2 | ctd:C422565 | |
| Drug | Dl-leucylglycine | 2.20e-04 | 46 | 58 | 3 | CID000079070 | |
| Drug | Cp 14 | 2.27e-04 | 9 | 58 | 2 | CID005487244 | |
| Drug | AC1MIZWH | 2.27e-04 | 9 | 58 | 2 | CID003083001 | |
| Drug | pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid | 2.27e-04 | 9 | 58 | 2 | ctd:C077792 | |
| Drug | d(CH2)5-Davp | 2.27e-04 | 9 | 58 | 2 | CID000123750 | |
| Drug | Mcp-tva-argipressin | 2.27e-04 | 9 | 58 | 2 | CID000122322 | |
| Drug | Hydrin 1 | 2.27e-04 | 9 | 58 | 2 | CID000195374 | |
| Drug | Duratocin | 2.83e-04 | 10 | 58 | 2 | CID000071715 | |
| Drug | JTP 4819 | 2.83e-04 | 10 | 58 | 2 | ctd:C094211 | |
| Drug | cyclo(Leu-Gly) | 2.83e-04 | 10 | 58 | 2 | CID000002902 | |
| Drug | AC1MIWZV | 2.83e-04 | 10 | 58 | 2 | CID003081474 | |
| Drug | sulfur mustard | 3.39e-04 | 130 | 58 | 4 | CID000010461 | |
| Drug | BM165 | 3.46e-04 | 11 | 58 | 2 | CID003352881 | |
| Drug | Dpmetyravp | 3.46e-04 | 11 | 58 | 2 | CID000119517 | |
| Drug | Rgd Peptide | 3.56e-04 | 239 | 58 | 5 | CID000104802 | |
| Drug | pY-5 | 4.14e-04 | 12 | 58 | 2 | CID000444861 | |
| Drug | 1-adamantaneacetic acid | 4.14e-04 | 12 | 58 | 2 | CID000123221 | |
| Drug | isocycloheximide | 4.40e-04 | 905 | 58 | 9 | CID000002900 | |
| Drug | CC270 | 4.61e-04 | 59 | 58 | 3 | CID006918852 | |
| Drug | AC1L9INI | 4.61e-04 | 59 | 58 | 3 | CID000445839 | |
| Drug | glycinamide | 4.84e-04 | 60 | 58 | 3 | CID000069020 | |
| Drug | AC1MIYR4 | 4.89e-04 | 13 | 58 | 2 | CID003082393 | |
| Disease | cathepsin D measurement | 2.74e-06 | 15 | 55 | 3 | EFO_0010611 | |
| Disease | Dysmenorrhea | 3.41e-06 | 2 | 55 | 2 | C0013390 | |
| Disease | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy | 3.41e-06 | 2 | 55 | 2 | cv:C0751587 | |
| Disease | psoriasis, COVID-19 | 3.41e-06 | 2 | 55 | 2 | EFO_0000676, MONDO_0100096 | |
| Disease | CADASIL Syndrome | 3.41e-06 | 2 | 55 | 2 | C0751587 | |
| Disease | CADASILM | 3.41e-06 | 2 | 55 | 2 | C1449626 | |
| Disease | Ischemia | 1.94e-05 | 28 | 55 | 3 | C0022116 | |
| Disease | Epidermolysis Bullosa Progressiva | 2.04e-05 | 4 | 55 | 2 | C0079297 | |
| Disease | Herlitz Disease | 2.04e-05 | 4 | 55 | 2 | C0079683 | |
| Disease | Hyponatremia | 2.04e-05 | 4 | 55 | 2 | C0020625 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 3.40e-05 | 5 | 55 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 3.40e-05 | 5 | 55 | 2 | C2608084 | |
| Disease | Polyuria | 3.40e-05 | 5 | 55 | 2 | C0032617 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 3.40e-05 | 5 | 55 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Junctional Epidermolysis Bullosa | 5.09e-05 | 6 | 55 | 2 | C0079301 | |
| Disease | oxytocin-neurophysin 1 measurement | 5.09e-05 | 6 | 55 | 2 | EFO_0802839 | |
| Disease | Early Pregnancy Loss | 5.20e-05 | 109 | 55 | 4 | C3830362 | |
| Disease | Miscarriage | 5.20e-05 | 109 | 55 | 4 | C4552766 | |
| Disease | Spontaneous abortion | 5.20e-05 | 109 | 55 | 4 | C0000786 | |
| Disease | Abortion, Tubal | 5.20e-05 | 109 | 55 | 4 | C0000822 | |
| Disease | Glioblastoma Multiforme | 5.58e-05 | 111 | 55 | 4 | C1621958 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 7.12e-05 | 7 | 55 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | bipolar II disorder | 9.48e-05 | 8 | 55 | 2 | EFO_0009964 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 1.94e-04 | 60 | 55 | 3 | EFO_0020690 | |
| Disease | Amelogenesis Imperfecta | 2.22e-04 | 12 | 55 | 2 | C0002452 | |
| Disease | Impaired cognition | 3.06e-04 | 14 | 55 | 2 | C0338656 | |
| Disease | FEV/FEC ratio | 4.11e-04 | 1228 | 55 | 9 | EFO_0004713 | |
| Disease | Glioblastoma | 4.38e-04 | 79 | 55 | 3 | C0017636 | |
| Disease | Dementia | 4.56e-04 | 17 | 55 | 2 | C0497327 | |
| Disease | Giant Cell Glioblastoma | 5.25e-04 | 84 | 55 | 3 | C0334588 | |
| Disease | Alopecia | 5.72e-04 | 19 | 55 | 2 | C0002170 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 5.72e-04 | 19 | 55 | 2 | DOID:2876 (is_marker_for) | |
| Disease | Cardiac Arrhythmia | 9.96e-04 | 25 | 55 | 2 | C0003811 | |
| Disease | Major Depressive Disorder | 1.10e-03 | 243 | 55 | 4 | C1269683 | |
| Disease | Thrombocytopenia | 1.34e-03 | 29 | 55 | 2 | C0040034 | |
| Disease | Autistic Disorder | 1.43e-03 | 261 | 55 | 4 | C0004352 | |
| Disease | Age related macular degeneration | 1.44e-03 | 30 | 55 | 2 | C0242383 | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.63e-03 | 32 | 55 | 2 | DOID:10155 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CCHDECAGGCSGPQD | 226 | P21860 | |
| CGGQDCSGSCQCFPE | 31 | Q14031 | |
| CCGSMCGDGCNGGYP | 141 | P07858 | |
| GVLLSGSCCECGCGR | 591 | P54756 | |
| PQVHSCGCCMGCGVG | 131 | Q5W186 | |
| CGCCMGCGVGTGAAD | 136 | Q5W186 | |
| CQGCGAFCHDDCIGP | 1516 | Q8IXJ9 | |
| CGPSELSCQAGGCKG | 421 | Q9BY79 | |
| CDCQAGYGGEACGQC | 181 | Q96HD1 | |
| CGECLGSGDPHCGWC | 516 | Q9HCM2 | |
| LCGGNGDCDCGECVC | 551 | P18564 | |
| CASSPCGEGGSCVDG | 661 | Q9UM47 | |
| YGSGCGGCGSSCCVP | 31 | Q6L8G5 | |
| SGCGGCGSSCCVPIC | 26 | Q6L8G4 | |
| QPSCCQTSSCGTGCG | 26 | P0C5Y4 | |
| CCCGGGGSTCCGRQA | 761 | Q9P2E7 | |
| PCSGRGECQCGHCVC | 511 | P16144 | |
| GILCGGFGRCQCGVC | 571 | P26010 | |
| VAGGPAAGCCCRDCC | 341 | Q14012 | |
| ACGCCEVCGAPEGAA | 61 | Q92743 | |
| CEGPCVEGCQCDAGF | 4381 | Q9Y6R7 | |
| CSVCCNVGPCSVCGG | 151 | Q96SL8 | |
| CCCTVGEGWGSGCRI | 1206 | Q8N2S1 | |
| GECCHTECLGGCSQP | 226 | P14616 | |
| CGSGCGGSGSSCCVP | 31 | Q6L8H4 | |
| VPTCSCSSCGKGGCG | 56 | Q6L8H4 | |
| SGCGGCGSSCCVPVC | 121 | Q6L8H4 | |
| CGGCGSGCGVPVCCC | 201 | Q6L8H4 | |
| GCCSQPSGGSSCCGG | 86 | Q5T7P2 | |
| SGYGGCGSGCCVPVC | 26 | Q6L8H2 | |
| VPACSCSSCGKGGCG | 76 | Q701N2 | |
| CCSQPSGGSSCCGGG | 91 | Q5T752 | |
| SGCGGCGSSCCVPVC | 26 | Q6L8G8 | |
| CGSCGSGCRGCGPSC | 21 | P26371 | |
| DCCECEPSGGSGCCH | 86 | Q5TA79 | |
| SCCGPISGGCCGPSS | 46 | O14633 | |
| ISGGCCGPSSGGCCN | 51 | O14633 | |
| GGCCNSGAGGCCLSH | 61 | O14633 | |
| CCESEPSGGSGCCHS | 91 | O14633 | |
| CCESEPSGGSGCCHS | 91 | Q5TA81 | |
| PGCCGGPSSEGGCCL | 41 | Q5TA77 | |
| PISSCCGSSSGGCGC | 36 | Q5TA78 | |
| GGCGCCSSEGGGCCL | 46 | Q5TA78 | |
| GTCIPCNCQGGGACD | 411 | Q13753 | |
| CRQGLGCGTTCSKCG | 2171 | Q8IWT3 | |
| SSCVGCTGEGPGNCK | 261 | Q6UXH1 | |
| CNCGGGPCDSVTGEC | 241 | Q16363 | |
| TCGCSQGGDCECFCA | 1201 | Q6ZRI0 | |
| CGGAPCHGVTGQCRC | 746 | O75095 | |
| VCGCGQGAACDPVTG | 1261 | O75095 | |
| PSCTLHCDCGGGADC | 1471 | O75095 | |
| GCAAPGCGEGQMTCS | 1411 | A2VEC9 | |
| GNSCGPCGTSQKGCC | 421 | O76011 | |
| GHCCPTCQGCTEGGS | 246 | Q6ZWJ8 | |
| CCPNDCSGCAFGGKE | 596 | Q6ZWJ8 | |
| QGLCGCVEETGACPC | 1106 | P25391 | |
| ACGSGGRCAVLGLCC | 91 | P01178 | |
| RTCHSCGCGCGCGKG | 71 | A0A286YF77 | |
| CGCGSGESGCAVCGC | 796 | O75592 | |
| CCSAPGGTECGECWG | 786 | Q6P9B9 | |
| CCCGAGGCAAVGENE | 56 | Q9H8M5 | |
| PCGSCGRRCSCGTNG | 1011 | Q9C0B9 | |
| VGIWGLVCCCCGGSG | 281 | P0DPA2 | |
| LVCCCCGGSGAGGAR | 286 | P0DPA2 | |
| ACGSGGRCAAFGVCC | 91 | P01185 | |
| PPGCSCGGCGSCGDR | 181 | Q9BSE2 | |
| DGGCCGGDGNNPNCC | 166 | P47989 | |
| ECRGGCAGGQCCGPL | 1481 | O94813 | |
| CCCIGSGCGGDPKCM | 261 | O00220 | |
| VECRGSCPGQGCCQG | 1486 | O75093 | |
| LCGDCQCCGCCGGDG | 186 | P48230 |